Merit Medical Acquires Acid Reflux Treatment from EndoGastric for $105 Million
Merit Medical Systems recently announced the acquisition of the Esophyx Z+ acid reflux treatment from Endogastric Solutions for a sum of $105 million, showing its strategic commitment to expanding its portfolio in the gastrointestinal device market. Esophyx Z+, a minimally invasive device, targets gastroesophageal reflux disease (GERD), a condition affecting approximately 20% of the U.S. […]